AEFI — The Five WHO Categories

AEFI — Adverse Event Following Immunization — is deliberately defined as broadly as Module 1’s AE definition was for conventional drugs: any untoward medical occurrence following immunization, which does not necessarily have a causal relationship with the vaccine. Just as an AE doesn’t imply the drug caused it, an AEFI doesn’t imply the vaccine caused it — the term captures everything that happens after vaccination, leaving causality as a separate, subsequent question, exactly the discipline Module 6 built for conventional drug causality assessment.

What vaccine safety surveillance adds beyond the conventional AE/ADR distinction is a five-category classification system specifically designed to sort AEFIs by their actual source, because the appropriate response differs dramatically depending on which category an event falls into. A vaccine product-related reaction is caused by one or more of the vaccine’s inherent properties — occurring even when the vaccine was correctly manufactured, stored, and administered, like extensive limb swelling that some DTP-containing vaccines are known to occasionally cause. A vaccine quality defect-related reaction, by contrast, is caused by an actual quality defect in the specific product or its administration device — a manufacturing-side failure, not a property of correctly-made product, and it triggers an entirely different investigative pathway back to the manufacturing batch.

An immunization error-related reaction — sometimes still called a programmatic error — is caused by inappropriate vaccine handling, prescribing, or administration: the wrong dose, the wrong route, contaminated equipment, or a cold-chain failure that degraded the vaccine before it was given. This category is where vaccine safety surveillance connects directly back to Module 12’s quality-system discipline: the appropriate response to an error-related reaction isn’t a signal against the vaccine product at all, it’s a CAPA investigation into the immunization delivery process itself — the vaccine may be entirely blameless, and the fix is a process correction, not a product action.

An immunization anxiety-related reaction arises from anxiety about the immunization process itself — vasovagal syncope, hyperventilation, sometimes cluster fainting episodes in adolescent vaccination settings — and it’s worth being precise that this category isn’t a dismissal of the patient’s experience: these are genuinely real physiological events, they’re simply not attributable to the vaccine’s biological properties, and recognising them as their own category prevents them from being miscounted as product safety signals. Finally, a coincidental event is caused by something other than the vaccine, a quality defect, an error, or anxiety — it happened to occur after vaccination purely by chance, or because of an underlying or emerging condition entirely unrelated to the vaccination. Getting an AEFI sorted into the right one of these five categories is the necessary first step before any causality assessment (Lesson 14.4) or signal-level action can happen at all.